Moteur de recherche d’entreprises européennes
Registre de Transparence de l'Union Européenne Eutr 04/07/2026 Registre de Transparence de l'Union Européenne
Vue d’ensemble
Texte
Pfizer Inc.
Identification Code: 4263301811-33 Registration Date: 2008-12-18 Last Update Date: 2026-06-29 Acronym: PFE Entity Form: Corporation Website: http://www.pfizer.com Registration Category: Companies & groups Levels of Interest: Global
Head Office
Address: 66 Hudson Boulevard E, New York, NY 10001, UNITED STATES Phone: +1 8008793477
EU Office
Address: Boulevard de la Plaine 17, 1050 Brussels, BELGIUM Phone: +32 25546211
Goals
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.
EU Legislative Proposals of Interest
- Revision of the EU pharmaceutical legislation
- EU Biotech Act
- EU Critical Medicines Act
- Urban Wastewater Treatment Directive
- Paediatric & Orphan Medicinal Products
- Vaccination policy
- Health Technology Assessment
- Chemical Policy
- IHI and research programs
- EU trade policy
- Industrial policy
- Research and innovation policy
- Pandemic preparedness
EU Supported Forums and Platforms
- Selected IHI consortia
- Critical Medicines Alliance
Communication Activities
Inter or Unofficial Groupings
N/A
Staffing
- Members (FTE): 1.5
- Members (Total): 3
- Members spending 50% or more of their time on activities in scope of the Register: 3
- Information on Members: 2 colleagues are full-time engaged in the EU/Brussels office and spend approx. 50% of their time on activities in scope of the Register. One colleague leads on trade and supply chain policy at EU level but has a global responsibility.
- EP Accredited Number: 2
Interests
- Budget
- Business and industry
- Competition
- Digital economy and society
- Economy, finance and the euro
- Environment
- External relations
- Foreign affairs and security policy
- Institutional affairs
- Public health
- Research and innovation
- Single market
- Taxation
- Trade
Structure
Organisation Members: In 2025 Pfizer was a member of: EFPIA, Vaccines Europe, EuropaBio, Amcham EU, BusinessEurope, European Policy Centre, European Business Summits, Friends of Europe.
Interest Represented
Promotes their own interests or the collective interests of their members
Financial Data
New Organisation: No
Closed Year (2025-01-01 to 2025-12-01)
Total Costs: €1,250,000 - €1,499,999
Intermediaries:
| Name | Representation Costs (€) |
|---|---|
| RPP Group | 50,000 - 99,999 |
| APCO Worldwide | 100,000 - 199,999 |
| Fleishman-Hillard | 25,000 - 49,999 |
| TEHA Group S.p.A. | < 10,000 |
| FIPRA International SRL | 25,000 - 49,999 |
Grants: None
Current Year
Intermediaries:
- RPP Group
- APCO Worldwide
- Fleishman-Hillard
- FIPRA International SRL
Grants: None
Complementary Information: The amount declared in answer (c) includes: relevant percentage of trade associations' work, consultants as declared, percentage of colleagues' fully loaded salary and office expenses.
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Pfizer Inc., New York, États-Unis.